Patent
   D459798
Priority
Mar 26 2001
Filed
Sep 24 2001
Issued
Jul 02 2002
Expiry
Jul 02 2016
Assg.orig
Entity
unknown
26
7
n/a
The ornamental design for pill tablet, substantially as shown and described.

FIG. 1 is a top view of our pill tablet design;

FIG. 2 is a bottom view thereof;

FIG. 3 is a long side view thereof;

FIG. 4 is an opposite long side view thereof;

FIG. 5 is a short side view thereof;

FIG. 6 is an opposite short side view;

FIG. 7 is a top view showing an embodiment of our pill tablet design;

FIG. 8 is a bottom view thereof;

FIG. 9 is a long side view thereof;

FIG. 10 is an opposite long side view thereof;

FIG. 11 is a short side view thereof;

FIG. 12 is an opposite short side view;

FIG. 13 is a top view showing another embodiment of our pill tablet design;

FIG. 14 is a long side view thereof;

FIG. 15 is an opposite long side view thereof;

FIG. 16 is a short side view thereof;

FIG. 17 is an opposite short side view;

FIG. 18 is a top view showing another embodiment of our pill tablet design;

FIG. 19 is a long side view thereof;

FIG. 20 is an opposite long side view thereof;

FIG. 21 is a short side view thereof; and,

FIG. 22 is an opposite short side view.

Becourt, Philippe, Desesquelle, Christian

Patent Priority Assignee Title
11279745, Apr 26 2019 Novo Nordisk A S Tolerogenic DNA vaccine
11466278, Nov 01 2016 Novo Nordisk A S Temperature based plasmid regulation system
D515202, Jul 19 2004 Merck Sharp & Dohme Corp Tablet
D553733, Apr 07 2006 Novartis AG Tablet
D589606, Jun 03 2008 Solvay Pharmaceuticals B.V. Pharmaceutical tablet
D636865, Aug 25 2010 KVK-Tech, Inc. Pharmaceutical tablet
D666376, Dec 01 2010 Intercontinental Great Brands LLC Lozenge
D666377, Dec 01 2010 Intercontinental Great Brands LLC Lozenge
D735315, Jun 25 2012 Amgen Inc Pharmaceutical tablet
D741990, Jul 30 2013 RB HEALTH US LLC Tablet
D744635, Jun 26 2014 Access Business Group International LLC Dietary supplement
D754840, Feb 03 2012 JOHNSON & JOHNSON CONSUMER INC Oral dosage form
D754841, Feb 03 2012 JOHNSON & JOHNSON CONSUMER INC Oral dosage form
D755949, Jul 30 2013 RB HEALTH US LLC Tablet
D778428, Feb 03 2012 JOHNSON & JOHNSON CONSUMER INC Oral dosage form
D787042, Apr 28 2015 Celgene Corporation Pharmaceutical tablet
D787043, Jun 23 2015 Celgene Corporation Pharmaceutical tablet
D795525, Mar 16 2016 Intercontinental Great Brands LLC Confection
D813372, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D821682, Mar 16 2016 Intercontinental Great Brands LLC Confection
D835257, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D835258, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D858741, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D906513, Mar 19 2019 Novo Nordisk A S Pill
D907760, Jan 20 2017 SOCIÉTÉ DES PRODUITS NESTLÉ S A Orally ingestible tablet
D947358, Mar 19 2019 Novo Nordisk A/S Pill
Patent Priority Assignee Title
5869096, Jul 14 1989 ALZA Corporation Oral osmotic device with hydrogel driving member
6027748, Jan 08 1997 PAUL ROYALTY FUND, L P Pharmaceutical tablet, completely coated, for controlled release of active principles that present problems of bio-availability linked to gastro-intestinal absorption
6165513, Jun 11 1997 Allergan Pharmaceuticals International Limited Film-coated tablet for improved upper gastrointestinal tract safety
D301764, Dec 21 1987 RHONE-POULENC RORER PHARMACEUTICALS INC Pharmaceutical tablet
D302051, Dec 21 1987 RHONE-POULENC RORER PHARMACEUTICALS INC Pharmaceutical tablet
D403396, Nov 28 1996 Astra Aktiebolag Tablet
D431076, Jul 07 1999 Merck Sharp & Dohme Corp Tablet
///
Executed onAssignorAssigneeConveyanceFrameReelDoc
Sep 24 2001Aventis Pharma S.A.(assignment on the face of the patent)
Oct 17 2001DESESQUELLE, CHRISTIANAVENTIS PHARMA S A ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0123580877 pdf
Oct 21 2001BECOURT, PHILIPPEAVENTIS PHARMA S A ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0123580877 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule